As obligate intracellular parasites, viruses need to cross the plasma membrane and deliver their genome inside the cell. This step is initiated by the recognition of receptors present on the host cell surface. Receptors can be major determinants of tropism, host range, and pathogenesis. Identifying virus receptors can give clues to these aspects and can lead to the design of intervention strategies. Interfering with receptor recognition is an attractive antiviral therapy, since it occurs before the viral genome has reached the relative safe haven within the cell. This chapter describes the use of an immunoprecipitation approach with Fc-tagged viral spike proteins followed by mass spectrometry to identify and characterize the receptor for the Middle East respiratory syndrome coronavirus. This technique can be adapted to identify other viral receptors.
Introduction
The fi rst step of the infection cycle of a virus is characterized by the interaction between the viral particle and the cell surface receptor. This interaction is followed by a series of events that lead to the delivery of the viral genome inside the cytoplasm. Viruses can use diverse types of molecules to bind and enter cells. The presence of a receptor is the principal determinant of cell, tissue and organ tropism, host range, and virulence. Therefore, identifying a receptor can give clues on pathogenesis, mode of transmission, zoonotic transmission potential and can lead to the design of targeted intervention strategies.
For the last three decades the identifi cation of virus receptors has been a major goal in virology. A group of viruses of which many receptors are known are coronaviruses (CoVs). Coronaviruses infect a wide range of avian and mammalian hosts and they are known for their ability to cross the species barrier [ 1 ] . This is exemplifi ed by the 2003 severe acute respiratory syndrome (SARS) pandemic that was caused by the SARS-CoV [ 2 ] . In 2012, a novel zoonotic CoV was identifi ed from a patient from Saudi Arabia that presented with a severe pneumonia [ 3 ] . This virus belongs to the same genus as SARS-CoV and was named Middle East respiratory syndrome coronavirus (MERS-CoV).
For CoVs, the viral Spike (S) protein primarily determines host and cell tropism. It is a type I membrane glycoprotein that is assembled in trimers in the viral envelope. The S protein can be functionally divided into two distinct subunits, S1 and S2. The S1 subunit binds to a cell surface receptor, whereas S2 facilitates fusion with cellular membranes.
Although virus receptors can be identifi ed using several methods [ 4 -8 ] , we identifi ed the MERS-CoV receptor using Fc-tagged S1 proteins in an immunoprecipitation assay followed by mass spectrometry [ 9 ] . This assay is basically similar to the method described by Li et al., for the identifi cation of the SARS-CoV receptor [ 10 ] . In this assay, the S1 subunit of MERS-CoV is ligated into a fusion vector to generate an S1-Fc fusion protein, for expression in HEK-293T cells and purifi cation using protein A-sepharose beads. Incubation of the S1-Fc proteins with whole cell lysate of virus-susceptible cells allows the precipitation of the virus receptor with the tagged S1. This complex can then be pulled down from the lysate using protein A-sepharose beads. Subsequently, mass spectrometry is employed to identify candidate protein receptors ( Fig. 1 ). These candidates must be evaluated functionally, which is done using fl ow-cytometric binding assays, infection blocking experiments using antibodies against the candidate receptor, and fi nally by attempting to infect non-susceptible cells that have been transfected with the candidate receptor. This method has been successfully employed for the rapid identifi cation of the SARS-CoV and MERS-CoV receptor [ 9 , 10 ] and is suitable for identifi cation of protein receptors with reasonable affi nity. Glycan receptors cannot be identifi ed using the described method; treatment of susceptible cells with glycosidases prior to infection can give an insight into the type of viral receptor. Success of the protein receptor pulldown using the S1-Fc as bait depends on the affi nity of S1-receptor interaction. A FACS-based S1-Fc cell-binding assay provides good insight in the strength of this interaction. The FACS-based S1-Fc assay is also instrumental to identify cell lines with high levels of receptor expression that can be used as a source for receptor affi nity-isolation. Alternatively, in the absence of a suitable cell line, homogenates of tissue targeted by the virus can also be used for immunoprecipitation of the receptor. 9. Anti-SARS nsp4 or antibody against other viral protein.
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10. Goat anti-rabbit FITC or other suitable secondary antibody.
11. Fluorescence microscope.
Methods
The virus used in this method, MERS-CoV EMC, was described previously [ 12 ] and is used as an example.
1. Isolate viral RNA from 140 µl of virus stock at 10 7 TCID 50 / ml using the viral RNA isolation kit, following manufacturer's instructions. The tissue RNA isolation kit was used to isolate RNA from 2 × 10 7 Huh-7 cells, following manufacturer's instructions ( see Note 1 ).
To convert RNA into cDNA we use SuperScript II reverse transcriptase but other reverse transcriptase enzymes can also be used. 
Validation of Receptor Identifi cation

RNA Isolation
cDNA Synthesis
We strongly recommend the use of Pfu Ultra II Fusion HS DNA polymerase, although other enzymes may be used. The PCR instructions in this protocol are optimized for the use of this polymerase. 9. Analyze the PCR product using an appropriate restriction enzyme or enzymes followed by standard agarose gel electrophoresis to confi rm that the PCR product is as expected.
10. Quantify the nucleic acid concentration of the PCR product using NanoDrop 1000 or similar spectrophotometer.
11. Store the PCR product at −20 °C.
1. The gene fragment encoding the Fc part of human IgG1 is PCR amplifi ed from pFUSE-hIgG1-Fc2 with fl anking restriction sites using the forward cgaattcagatctTGAGCC CAAATCTTGTGAC and reverse primer cggatccTCATT TACCCGGAGACAGG. Subsequently, the EcoRI/BamHI digested PCR fragment can be cloned into the EcoRI-BglII digested pCAGGS vector creating the pCAGGS-Fc vector.
2. Digest the S1 PCR product and the pCAGGS-Fc vector by adding the following into separate 1.5 ml tubes: 2 µl of the appropriate 10× restriction buffer, 1 µg of DNA (PCR product or vector), H 2 O up to 20 µl, 20 U of the appropriate
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restriction enzyme ( Eco RI and Bam HI in the example in Subheading 2.1 ).
3. Mix gently by pipetting and incubate at 37 °C for 1 h.
4.
Electrophorese the restriction digests of the vector and S1 PCR product in a agarose gel, identify the products and cut out the gel slices containing the digested products.
5.
Purify the DNA products from the agarose slices using a gel extraction kit, elute the DNA into H 2 O and quantify the nucleic acid concentrations using a NanoDrop.
6. Ligate the digested S1 PCR product into the pCAGGS-Fc vector by adding the following to a 1.5 ml tube: 2 µl 10× T4 ligation buffer, DNA of digested vector and S1 PCR product in a 1: 
Colony PCR
9. Perform a restriction digest and analyze the products by standard agarose gel electrophoresis to confi rm the plasmid DNA is correct.
10. Determine DNA concentration using a NanoDrop or spectrophotometer and prepare a DNA stock of 1 µg/µl. 3. Two hours prior to transfection, remove medium from 293T cells and replace with 30 ml of fresh prewarmed 293T cell growth medium.
4.
For each T175 fl ask, prepare the DNA transfection solution as follows: add 18 µl of 1 µg/µl pCAGGS-MERS-CoV-S1-Fc plasmid DNA (Subheading 3.5 , step 10 ) to 3 ml of serumfree DMEM and mix by pipetting.
5. Add 54 µl of 1 mg/µl PEI to the transfection solution and mix.
6. Incubate at room temperature for 30 min.
7. Add the DNA/PEI complex dropwise to the T175 fl ask and gently swirl to mix.
Incubate cells 4-12 h (determine experimentally).
9. Aspirate the medium from the transfected cells and replace with 40 ml of HEK-293T expression medium, incubate at 37 °C with 5 % CO 2 for 6 days.
10. Prepare 50 % (w/v) protein-A sepharose beads: Add 0.25 g of protein-A sepharose CL-4B to a tube, add 10 ml PBS to form a slurry, centrifuge for 2 min at 2,000 × g , remove supernatant, and repeat two more times. Pellet the beads for 2 min at 2,000 × g and resuspend in 1.4 ml PBS per tube (50 % w/v), the fi nal volume will be ~2.8 ml.
11. Collect the expression medium from the transfected HEK-293T cells into 50 ml tubes and centrifuge at 2,850 × g for 10 min to remove cell debris.
12. Transfer medium to new 50 ml tubes and centrifuge again at 2,850 × g for 15 min.
13. Transfer cleared medium to new 50 ml tubes and keep it on ice; take a 100 µl aliquot and store at −20 °C.
14. Add 0.5 ml of washed protein-A sepharose beads (50 % w/v) and 800 µl of 1 M Tris-HCl pH 8.0 to each 40 ml supernatant to neutralize the pH and incubate overnight, rotating at 4 °C ( see Note 5 ).
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15. Collect the protein-A sepharose beads by centrifugation at 2,000 × g for 15 min (see Note 6 ). 16 . Pool all the protein-A sepharose beads together in a 50 ml tube and wash three times with 10 ml PBS.
17. After the fi nal centrifugation, resuspend the protein-A sepharose beads in 1 ml of 0.5 M acetic acid pH 3 elution buffer and incubate for 1 min at room temperature.
18. Centrifuge the protein-A sepharose beads at 14,000 × g for 10 min and transfer the supernatant to a 1.5 ml tube.
19. Repeat steps 17 and 18 twice more to elute any remaining S1-Fc protein from the protein-A sepharose beads.
20. To remove any remaining protein-A sepharose beads in the supernatant repeat step 18 once and transfer supernatant to a fresh tube.
21.
To neutralize the pH of the eluted S1-Fc protein, add 200 µl of 3 M Tris-HCl pH 8.8 (fi nal pH 7.5).
22. Quantify the protein concentration using a NanoDrop at 280 nm.
23. To analyze the size of the eluted S1-Fc protein, run 2 µg of the protein in a standard 10 % SDS-PAGE gel.
24. Aliquot the S1-Fc protein and store at −80 °C.
1. Seed 5 × 10 7 Huh-7 cells in 100 mm dishes with growth medium and incubate at 37 °C for 24 h to allow the cells to become confl uent.
2. Wash the adherent cells twice with ice-cold PBS and allow the PBS to drain off.
3. Add 1 ml of DDM lysis buffer onto the cells and gently rock the dish to cover the entire cell sheet.
4. Scrape adherent cells off the dish with either a rubber policeman or a plastic cell scraper and transfer the cell suspension into a fresh centrifuge tube. Gently rock the suspension on either a rocker or an orbital shaker at 4 °C for 15 min to lyse the cells.
5.
Centrifuge the lysate at 14,000 × g in a precooled microcentrifuge for 1 min.
6. Immediately transfer the supernatant to a fresh centrifuge tube and discard the pellet.
1. Prepare a 50 % (w/v) protein-A sepharose bead slurry as in Subheading 3.6 , step 10 .
2. Add 100 µl of the protein A-sepharose bead slurry to every 1.5 ml of cell lysate and incubate at 4 °C for 10 min on a rocker or orbital shaker ( see Note 7 ).
3. Remove the beads by centrifugation at 14,000 × g at 4 °C for 1 min and carefully transfer supernatant to a fresh tube. 1. Add 2.5 µg of the purifi ed S1-Fc fusion protein (Subheading 3.6 , step 24 ) to 1.5 ml of the Huh-7 precleared lysate and incubate for 1 h at room temperature on a rocker or an orbital shaker.
Immunoprecipitation
2. Use 1.5 ml of the Huh-7 precleared lysate, without the purifi ed S1-Fc fusion protein, as a negative control and incubate as described in step 1 .
3. Capture any immunocomplexes between the S1-Fc fusion protein and the precleared Huh-7 cell lysate by adding 150 µl of the protein A-sepharose 50 % bead slurry to 1.5 ml of the lysates in Subheading 3.7 , step 2 , gently mix overnight at 4 °C on either a rocker or an orbital shaker.
4.
Collect the protein A-sepharose beads by pulse centrifugation (i.e., 5 s in the microcentrifuge at 14,000 × g ). Discard the supernatant and wash the protein A-sepharose beads twice with DDM lysis buffer and once in PBS alone. Discard the supernatants. 2. Add 10 µl of the 10 µg/ml trypsin working solution to every 1 mm gel slice so that each slice is fully immersed in the trypsin working solution.
Resuspend the protein
3. Incubate the gel slices for 30 min at room temperature. 4 . Check that the gel pieces are still fully covered by the trypsin solution, if not, add some more trypsin working solution.
5. Incubate overnight at 37 °C; shaking not necessary. 2. Incubate at 37 °C for approximately 5 min (until complete disassociation of the cells).
3. Add 1 ml of PBS and mix it by pipetting up and down.
4. Transfer the cell suspension in to a new tube and add additional 5 ml of PBS.
5. Centrifuge at 400 × g for 5 min.
6. Resuspend the cells in 2 ml PBS and count the cells using the counting chamber.
7. Place 5 × 10 5 cells in a 96 well "v" bottom plate and add S1-Fc or 5 µg/ml antibody against protein under investigation such as goat anti-DPP4 polyclonal antibodies in this example, or without any protein as a control, in volume of 50 µl.
8. Incubate on ice for 30 min.
9. Wash the cells three times with PBS containing 0.5 % BSA.
10. Add 50 µl of FITC-labelled goat anti-human IgG or FITClabelled rabbit anti goat serum (5 µg/ml) or any other labelled secondary antibody depending on the origin of the antibody in step 7 .
11. Incubate on ice for 30 min and wash the cells three times with PBS.
12. Resuspend the cells in 190 µl of PBS.
13. Analyze the cells for any fl uorescence by fl ow cytometry (Fig. 2 ). 2. After 24 h of transfection, wash the cells with Cos-7 growth medium and incubate the cells with virus under investigation, e.g., MERS-CoV-EMC for 1 h.
Cloning and Expression of Human DPP4 or
3. Wash the cells two times with Cos-7 growth medium containing 1 % FCS to remove any unbound virus and after fi nal wash add 3 ml of fresh medium.
4.
Incubate the cells at 37 °C with 5 % CO 2 for 24 h.
5.
Fix the cells with 4 % formaldehyde solution for 10 min. 
